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ABSTRACT 
 Individual animals vary greatly in their responses to pathogenic challenge. One 
such response that remains understudied in animals is the ability to minimize the per-
pathogen costs of infection on host fitness. Phenotypically, this presents as individuals 
with milder clinical signs of disease despite substantial pathogen burdens. Hosts that 
develop milder pathology, a measure of tissue damage, or express milder sickness 
behaviors are therefore described as being tolerant. Because tolerant hosts survive 
infection through damage limitation but not necessarily pathogen elimination, they may 
be more likely to infect others by shedding higher numbers of pathogen over longer 
windows of time. This suggests that tolerant hosts may also be more competent, with 
direct implications on infectious disease dynamics. Here, I characterize sources of 
variation in disease phenotype and its effect on epidemic outcomes, using an 
ecologically-relevant disease system as a model. Specifically, I use captive studies on 
house finches experimentally-infected with Mycoplasma gallisepticum to explore 
potential mechanisms underlying tolerance, the impacts of tolerance on pathogen 
transmission, and finally, novel ways to measure individual disease outcomes and 
tolerant phenotypes.
1 
CHAPTER 1.    GENERAL INTRODUCTION 
Individual animals may express a range of disease phenotypes depending on the 
nature of their host-pathogen interactions. Tolerance, in particular, is an adaptive host 
response that minimizes the per-pathogen fitness costs of infection (Caldwell et al., 1958; 
Roy and Kirchner, 2000; Medzhitov, Schneider and Soares, 2012; Råberg, 2014). Though the 
physiological mechanisms of tolerance in vertebrates remain poorly defined, authors have 
begun to document its impacts on individuals and populations (Schneider and Ayres, 2008; 
Råberg, 2014; Burgan et al., 2019). Because tolerant hosts tend to show milder clinical signs 
and higher survival, their potential for prolonged pathogen shedding may facilitate the 
establishment and spread of epizootics. Increasingly, disease ecologists are emphasizing the 
role of individual variation in shaping these population-level processes (Lloyd-Smith et al., 
2005; Burgan et al., 2019; Martin et al., 2019). 
Here, I use an ecologically-relevant disease system to evaluate how heterogeneous 
host responses shape the expression of disease phenotype, with knock-on effects for 
conspecifics. Finch mycoplasmosis is a recently emerged infectious disease of North 
American songbirds that causes variable inflammation of the soft tissues surrounding the eye, 
or conjunctiva. It is caused by a bacterial pathogen, Mycoplasma gallisepticum (MG), to 
which house finches (Haemorhous mexicanus) are particularly susceptible (Ley, Berkhoff 
and McLaren, 1996). Phylogenetic analysis suggests that a single host-jump out of poultry in 
1988 initiated the 1994 epizootic (Delaney et al., 2012; Hochachka et al., 2013), which 
resulted in a marked density-dependent population decline in an otherwise widely successful 
bird species (Hochachka and Dhondt, 2000). In the intervening decades finch MG has spread 
across the continental United States and into southern Canada (Dhondt, Tessaglia and 
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Slothower, 1998; Staley et al., 2018), along with the emergence of new strains of varying 
virulence. However, given the different lengths of pathogen establishment, we see substantial 
inter- and intra-population-level differences in how individuals respond to infection 
(Adelman et al., 2013b), making finch mycoplasmosis an ideal disease system to study 
disease tolerance. Moreover, because seasonal outbreaks persist across North America 
(Hosseini, Dhondt and Dobson, 2004; Dhondt et al., 2005), understanding how tolerance 
may change epizootic outcomes at the population-level is highly relevant.  
To begin, the two studies presented in Chapter 2 examined the mechanistic 
underpinnings of disease tolerance by evaluating how inflammation shapes host phenotype. 
Because inflammation drives conjunctival pathology, and pathology confers direct fitness 
costs to the host, I hypothesized that damping the inflammatory pathways would shift birds 
toward more tolerant phenotypes. As such, in the first study, I administered non-steroidal 
anti-inflammatory drugs to experimentally-infected house finches and compared clinical 
outcomes (e.g., pathology) across treated and untreated birds receiving the same inoculation 
dose of pathogen. The second study then tested whether restricting treatment to the first week 
of infection could change an individual’s phenotypic trajectory for the entire course of 
disease.  
Chapter 3 explores the impact of disease tolerance on host competence by simulating 
outbreaks in house finch pairs. Host competence describes the ability of a diseased individual 
to infect others (Martin et al., 2019). Therefore, whether tolerant hosts are more or less 
competent should depend on how tolerance affects the transmission pathway. By breaking 
disease tolerance into tissue-specific and behavioral components, I tested how differences in 
pathology and sickness behavior, specifically anorexia, affected time to transmission. 
3 
Because pathology facilitates pathogen deposition onto fomites (Adelman et al., 2013a), 
hosts expressing milder clinical signs of infection should be worse at infecting others. In 
contrast, hosts expressing milder sickness behaviors should come into contact with 
susceptible hosts and potential fomites more frequently (Adelman and Hawley, 2017), 
providing more opportunities to infect others. Thus, I predicted that tissue-specific tolerance 
would delay transmission whereas behavioral tolerance would accelerate it, resulting in 
opposite but not necessarily equal effects on host competence. 
Finally, Chapter 4 introduces novel techniques to characterize variations in host 
phenotype within multidimensional disease space. Researchers traditionally score eye lesions 
using a scale from 0 (absent) to 3 (severe) (Sydenstricker et al., 2006), which provides 
adequate resolution for studies looking at group differences. However, it also limits the kinds 
of questions that can be asked, like how pathology changes over the course of infection, 
when birds in early or late infection score the same values. First, I used geometric 
morphometrics to assess changes in pathology based on eye shape, defined by the physical 
displacement of anatomical landmarks. Then, I used community analysis to explore 
differences in pathology based on the presence or absence of a unique set of binary 
descriptors. By approaching the same types of data in different ways, both techniques lent 
unique insights to a well-characterized disease system. 
In general, this dissertation leans into the noise of individual variation to critically 
evaluate how host phenotype modulates disease impacts. It characterizes the sources of 
variation on physiological and evolutionary scales and tests the effect of variation on 
epidemic outcomes. Finally, it contributes to an expanding literature that considers individual 
variation in the host response an integral force guiding disease dynamics at the group- and 
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population-levels (Lloyd-Smith et al., 2005; VanderWaal and Ezenwa, 2016; Burgan et al., 
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CHAPTER 2.    MODULATING DISEASE PHENOTYPE IN A SONGBIRD: A ROLE 
FOR INFLAMMATION IN DISEASE TOLERANCE? 
Introduction 
When the immune system detects infection, it can kill the invading pathogen 
(resistance) or minimize per-pathogen reductions to host fitness (tolerance) (Råberg, 2014). 
Though resistance permits pathogen clearance with the potential for sterilizing immunity, it 
also poses a risk for collateral tissue damage (‘immunopathology’) and exacerbated sickness 
behaviors that can reduce fitness in the immediate term (Adelman and Hawley, 2017). In 
contrast, tolerance permits pathogen persistence by minimizing the costs to the host of 
pathogen invasion and replication. Rather, animals can harbor high pathogen loads while 
maintaining tissue function and expressing normal, fitness-enhancing behaviors, which may 
increase the probability of contacting conspecifics and spreading pathogens (Adelman and 
Hawley, 2017). Thus, while tolerance may be an adaptive survival strategy for individual 
hosts, it could also support pathogen fitness via increased transmission to new hosts (Råberg, 
Graham and Read, 2009; Boots et al., 2009; Sears et al., 2011). Identifying the mechanisms 
that mediate host tolerance at the individual-level can therefore improve our understanding of 
infectious disease dynamics in the wild.  
Despite the potential for strong effects on epidemic outcomes, the physiological 
mechanisms underlying tolerance in animals remain largely unknown (Råberg, 2014). 
Among vertebrates, one promising mechanism involves dampening the pro-inflammatory 
response to infection, responsible for local swelling, release of pro-inflammatory cytokines, 
and production of free radicals (Graham, Allen and Read, 2005; Råberg, Graham and Read, 
2009; Sears et al., 2011). Because these responses can induce significant damage to a host’s 
own tissues, incurring serious fitness costs, reducing such inflammatory mediators could 
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preserve fitness during infection and increase tolerance (‘damage limitation,’ see Vale, 
Fenton and Brown, 2014 for review). Of note, tolerance and pathogen clearance need not be 
mutually exclusive (Restif and Koella, 2003; Restif and Koella, 2004). For instance, a host 
could still mount a targeted, adaptive immune response in the absence of over-exuberant 
inflammation, effectively reducing pathogen burden while minimizing self-harm (Hurtado, 
2012; Adelman et al., 2013). In the experiments reported here, we explore the potential for 
reduced inflammation to enhance tolerance, while still allowing the expression of effective 
resistance mechanisms. To do so, we test the effect of non-steroidal anti-inflammatory drugs 
(NSAIDs) on host responses in an ecologically relevant host-pathogen system, house finches 
(Haemorhous mexicanus) experimentally infected with Mycoplasma gallisepticum (MG). 
MG is a bacterial pathogen of poultry that was first isolated in North American 
songbirds in the mid-1990s (Ley, Berkhoff and McLaren, 1996; Delaney et al., 2012). House 
finches are highly susceptible to infection, and the initial outbreak decimated their 
populations in the eastern United States (Hochachka and Dhondt, 2000). In subsequent 
decades, MG has become endemic in house finch populations across North America and 
seasonal epidemics continue annually (Hosseini, Dhondt and Dobson, 2004; Dhondt et al., 
2005). 
Finch isolates of MG have a tropism for the soft tissues surrounding the eye or 
conjunctiva (Ley, Berkhoff and McLaren, 1996). In addition to inducing sickness behaviors 
like lethargy and anorexia, infection with MG can cause gross pathology that satisfies the 
cardinal signs of inflammation, including: periocular swelling (tumor), increased perfusion 
leading to erythema (rubor) and heat (calor), blepharospasm, or squinting, which can be used 
as a proxy for pain (dolor), and impaired vision (functio laesa) (Rather, 1971). Infection can 
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also cause tissues to become leaky, or exudative, such that purulent discharge functionally 
seals the eye (Ley, Berkhoff and McLaren, 1996). Given the importance of inflammation to 
disease progression, finch mycoplasmosis provides an ideal system for exploring its role in 
tolerant versus resistant disease phenotypes. 
Here, we first test whether two NSAIDs, which differ in target specificity and site of 
application, can induce tolerant phenotypes during experimental infection. NSAIDs are 
broadly used in human and veterinary medicine to relieve pain and inflammation caused by 
noxious stimuli. They work by inhibiting cyclo-oxygenase (COX), a family of enzyme 
responsible for prostaglandin synthesis and release in target tissues. COX-1 prostaglandins 
are protective, with constitutive expression in key tissues like the gastric mucosa, kidney, 
brain, and bloodstream that helps maintain normal physiology (Mitchell et al., 1993). COX-2 
prostaglandins are reactive and their expression is induced by inflammatory cytokines at the 
site of tissue injury (Mitchell et al., 1993). They are responsible for signaling pain and further 
escalating the inflammatory response via recruitment of immune cells (Aoki and Narumiya, 
2012).  
Using wild-caught, captive house finches, we tested how a non-selective COX 
inhibitor, flurbiprofen, and a COX-2 specific inhibitor, meloxicam, impacted disease 
tolerance. We administered flurbiprofen daily in an ophthalmic preparation applied directly 
to the target tissue (conjunctiva) via eye drop. In contrast, we administered meloxicam daily 
in an oral suspension that must be absorbed from the gut. We predicted that NSAID therapy 
would reduce clinical signs during infection without changing the bacterial burden as 
compared to untreated, but infected, birds. We also predicted that by treating at the site of 
tissue injury, topical NSAIDs would be more effective than systemic NSAIDs at reducing 
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eye pathology. We tracked eye pathology and pathogen load over twenty-eight days 
following experimental inoculation with MG. We additionally measured antibody titers to 
better understand how NSAID treatment affects the activation of adaptive immunity. 
In a follow-up study, we tested whether inflammation during an early “critical 
window” might predict individual disease trajectories over the course of infection. An earlier 
study found that differences in inflammatory signaling 24 hours after inoculation predicted 
differences in tolerance at peak infection 7-14 days later (Adelman et al., 2013). These 
findings as well as results from the NSAID trial informed the objectives of this second study. 
To test the critical window hypothesis, we experimentally infected house finches and 
restricted NSAID treatment to either 3, 7, or 28 days post-inoculation and compared disease 
outcomes out to 38 days against positive controls. We predicted that if a critical window 
exists, birds treated with NSAIDs during the first week of infection would express the same 
tolerant disease phenotype as those treated daily over the course of infection. 
Methods 
Capture Sites and Permits (Both Experiments) 
House finches used in the first study were captured between 5-15 September, 2016, 
using mist nets at four private residences around Ames, Iowa, USA (42.0254675° N, 
93.62688° W). House finches used in the second study were captured between 23 June and 
26 August, 2018 at two private residences in Ames using both mist nets and feeder traps. All 
procedures were approved under permits from the Iowa Department of Natural Resources 
(SC1133), the U.S. Geological Survey Bird Banding Lab (23952), the U.S. Fish and Wildlife 
Service (MB82600B), the Institutional Animal Care and Use Committee at Iowa State 
University (Experiment 1: 7-16-8311-Q; Experiment 2: 6-17-8543-Q), and the Institutional 
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Biosafety Committee at Iowa State University (Both experiments: 17-I-0021-A). 
Initial Housing and Quarantine (Both Experiments) 
At capture, birds were assigned an eye score (0-3 per eye; Sydenstricker et al., 2006) 
to assess eye pathology consistent with mycoplasmal conjunctivitis. Eyes that scored “0” 
were clinically normal, those that scored “1” had mild inflammation, those that scored “2” 
had moderate inflammation often with conjunctival eversion, and those that scored “3” had 
severe inflammation with purulent discharge, crusting, and eye spasm. Birds scoring “0” in 
both eyes were considered eligible for this study and brought into captivity. Birds were 
dusted with GardenTech Sevin-5 Ready-To-Use 5% Dust (TechPac, LLC., Atlanta, GA) to 
remove any ectoparasites before entering the captive facility, where they were housed in 
individual cages (76 cm x 46 cm x 46 cm) with access to food and water ad libitum. Birds 
received a 50:50 mix of black oil sunflower seed and food pellets (Daily Maintenance 
Nibbles, Roudybush, Inc., Woodland, CA) throughout the study. Birds were started on a 12 
hr Light: 12 hr Dark cycle for the first month in captivity, then transitioned to an 11 hr Light: 
13 hr Dark cycle to mimic natural conditions. Day length remained constant throughout the 
duration of study period, and rooms were maintained at 23°C.  
Birds were monitored every three days for two weeks for clinical signs of disease. A 
blood sample was taken from the ulnar vein 14 days after capture to test for the presence of 
anti-MG IgY antibodies using enzyme-linked immunosorbent assay (ELISA, see details in 
“Sampling, polymerase chain reaction, and serology”). Briefly, the ulnar vein was punctured 
using a 26G needle and blood was collected in a heparinized microcapillary tube. Blood was 
then separated by centrifugation and plasma stored at -20°C until the ELISA. Individuals that 
remained nonclinical and had ELISA sample:positive (S/P) ratios < 0.0229 on light 
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spectroscopy (Hawley et al., 2011) were enrolled in this study. Birds that did not meet these 
criteria were released at their original capture site (n = 4). Birds retained for the study were 
assigned an aluminum leg band with a unique numeric identifier. 
Birds in the second study were processed in the same manner as birds in the first 
study, except where detailed below. Birds were maintained on a 12 hr Light: 12 hr Dark 
cycle throughout the duration of this study, with ad libitum access to water, grit, cuttlebone, 
and a 20:80 mix of black oil sunflower seeds and food pellets (Daily Maintenance Nibbles, 
Roudybush, Woodland, CA). Due to unexpected mortalities during other experiments in 
2017, all birds received a five-day prophylactic course of dimetridazole (Cankerex Plus, 
Medpet, Benrose, South Africa) treatment at a dilution of 0.025% in their drinking water. 
Additionally, four birds received a prophylactic for coccidiosis: 2.5% toltrazuril (Endocox at 
1.22 g/L water; Jedd’s Fine Avian Products, Anaheim, CA) in their drinking water for 3 
consecutive days for 3 weeks, following by 3 days every 2 weeks until recruitment into the 
transmission study. The birds also received probiotics in their drinking water once per week 
to regulate the intestinal microflora (Bene-Bac Plus Bird and Reptile at 1 g/L water; PetAg, 
Inc., Hampshire, IL). Both treatments were discontinued at least one week before NSAID 
treatments began, and these birds were evenly distributed across experimental groups. 
Protocols for Experiment 1: Tolerance Induction Study 
NSAID and Mycoplasma treatments 
Animals were randomly assigned to one of three NSAID treatment groups: 1) control 
(no NSAID) 2) oral meloxicam (systemic NSAID), or 3) topical flurbiprofen (local NSAID). 
Treatment began one day prior to experimental inoculation with MG (day -1, Figure 2.1) to 
maximize the effect of prophylactic analgesia, the standard of care in pre-operative 
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veterinary patients (Hawkins and Paul-Murphy, 2011). Birds in the meloxicam treatment 
group (n = 8) received 1 mg/kg meloxicam per day via micropipette, for a total fluid volume 
of 100 µL (meloxicam + water). Dosages were adjusted once per week at the time of 
weighing. Birds in the flurbiprofen treatment group (n = 10) received daily eye drop therapy 
via application of 0.03% flurbiprofen ophthalmic solution (Bausch and Lomb, Inc., Tampa, 
FL). Topical treatment was restricted to either the left or the right eye throughout the study, 
such that the contralateral eye served as a self-control. Control eyes received one drop of 
artificial tears containing 1.4% polyvinyl alcohol (Akorn, Inc., Lake Forest, IL) daily. Eye 
drops were applied separately and allowed to absorb/drain for at least 1 minute before 
proceeding with treatments. Flurbiprofen-treated birds also received 100 µL oral water each 
day to standardize fluid consumption across experimental groups. Control birds (n = 10) 
received 100 µL oral water and no NSAIDs.  
 
Figure 2.1  Timeline for experiment 1, the tolerance induction study. Twenty-eight house 
finches were divided into three NSAID treatment groups: (1) no treatment, (2) oral 
meloxicam, or (3) topical flurbiprofen. All treatments began one day prior to experimental 
inoculation with Mycoplasma gallisepticum (MG). 
On 21 October 2016 (experimental day 0), birds were inoculated with an expanded 7th 
generation in vitro passage of finch MG isolate ‘VA1994’ (stock ID 7994-1-7P 2/12/09; D. 
H. Ley, North Carolina State Univ., College of Veterinary Medicine, Raleigh) suspended in 
Frey’s medium. A volume of 25 µL containing a total of 1.88 x 105 color-changing units 
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(CCU) was applied to each eye via micropipette, and birds were maintained in horizontal 
recumbency until fluid dissipated below the eye rim.  
Sampling, polymerase chain reaction, and serology 
Eyes were scored three times per week using the same scale applied at initial capture, 
starting on day -1 (baseline, pre-inoculation, Figure 2.1) by a single observer who was 
blinded to treatments (J. Adelman). Conjunctival swabs were taken on days -1, 3, 7, 14, 21, 
and 28 of infection to evaluate pathogen load (Figure 2.1). To do so, the ventral eyelid 
margin was abducted using sterile forceps, and a sterile cotton-tipped applicator dipped in 
tryptose phosphate buffer (TPB) was inserted and rotated for 5s. Swabs were then immersed 
in dedicated microcentrifuge tubes with 300 µL TPB, wrung out for 5s, and stored at -20°C.  
We used the Qiagen DNEasy Blood and Tissue kit (Cat no. 69504/69506, Qiagen, 
Valencia, CA) to extract DNA from the swab samples suspended in TPB, followed by 
quantitative polymerase chain reaction (qPCR) targeting the mgc2 gene, which encodes a 
well-described cytadhesin-like protein, using previously published conditions and primers 
(Grodio et al., 2008). Blood samples were taken, as described above, on days 14 and 28 of 
infection (Figure 2.1). Samples were immediately centrifuged to separate the plasma, then 
stored at -20°C for later serological evaluation using a commercially available ELISA kit, 
adapted for use in finches (cat # 99-06729, IDEXX Laboratories, Inc., Westbrook, ME; 
validated in Grodio, Buckles and Schat, 2009).  
Protocols for Experiment 2: Critical Window Study 
NSAID and Mycoplasma treatments 
In the second study, animals were randomly assigned to one of four NSAID treatment 
groups: 1) control (no NSAID, n = 8), 2) meloxicam through day 3 (3-day, n = 7), 3) 
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meloxicam through day 7 (7-day, n = 8), and 4) meloxicam through day 28 (28-day, n = 8). 
Treatment began two days prior to experimental inoculation with MG (day -2, Figure 2.2) to 
maximize the effect of prophylactic analgesia. Birds in experimental treatment groups 
received 1 mg/kg meloxicam per day orally via micropipette. Control birds received a 
comparable volume of water at 2 µL/kg per day. Dosages were adjusted once per week based 
on weight.  
 
Figure 2.2  Timeline for experiment 2, the critical window study. Thirty-one house finches 
were divided into four NSAID treatment groups: (1) no treatment, (2) oral meloxicam 
through day 3, (3) oral meloxicam through day 7, or (4) oral meloxicam through day 28. All 
treatments began two days prior to experimental inoculation with Mycoplasma gallisepticum 
(MG). 
On 14 September 2018 (experimental day 0), birds were inoculated with the same 
finch MG isolate ‘VA1994’ used in experiment 1 (stock ID 7994-1-7P 2/12/09; D. H. Ley, 
North Carolina State Univ., College of Veterinary Medicine, Raleigh). A volume of 25 µL 
containing a total of 1.88 x 105 color-changing units (CCU) was applied to each eye via 
micropipette, and birds were maintained in horizontal recumbency until fluid dissipated 
below the eye rim.  
Sampling, polymerase chain reaction, and serology  
In the second study, eyes were scored every 2 days during the hypothesized critical 
window (through day 7), then every 3-4 days through day 38 by a single observer blinded to 
treatments (J. Adelman) (Figure 2.2). Lesions were further characterized using the presence 
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(1) or absence (0) of the following pathological descriptors: blepharospasm, crusting, 
erythema, eversion, exudate, and swelling. Conjunctival swabs were collected on days -1, 3, 
7, 14, 21, 28 and 38 of infection to evaluate pathogen load and 75-150 µL blood samples 
were taken on days 14, 28, and 38 of infection (Figure 2.2). All samples were processed 
using the same materials and methods as detailed for experiment 1. 
Data Analysis (Both Experiments) 
We ran the same core analyses on experiments 1 and 2. However, results were 
analyzed separately given the unique birds, treatments, and research questions specific to 
each experiment. Data on eye score, pathogen load, and antibody titers were analyzed with 
linear mixed-effects models in R, version 3.5.2 (R Development Core Team, 2018) using 
packages nlme and lsmeans (Pinheiro, 2000; Lenth, 2016). The models included day post-
inoculation (DPI), treatment group, and their interaction as fixed effects, as well as bird ID as 
a random effect. Eye pathology was measured as the sum of left and right eye scores per bird 
per day. Pathogen load was measured as the number of mgc2 copies detected per eye per day, 
which was then summed by individual and log10 transformed to control for non-normality. 
All models included an AR1 autocorrelation function to control for temporal autocorrelation. 
When treatment group significantly predicted model response (p < 0.05), we used Tukey 
pairwise comparisons to identify treatments associated with different clinical outcomes. 
Although flurbiprofen was administered unilaterally to birds in experiment 1, visual 
inspection of pathology and pathogen load over time revealed mild differences between 
treated and untreated eyes (see Appendix). We verified this pattern with linear mixed-effects 
models with pathology or pathogen load as response variables and day post-inoculation, 
treatment, and their interaction as fixed effects, eyes nested within bird as a random effect, 
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and an AR1 autocorrelation function. Although treated eyes showed a marginal increase in 
pathology compared to untreated eyes (Appendix, LMM: F1,9 = 4.33, p = 0.07), pathogen 
loads did not differ (Appendix, LMM: F1,9 = 2.00, p = 0.19). Moreover, differences across 
eyes were negligible compared to differences across treatment groups. As such, all analyses 
use ‘bird’ as the experimental unit across treatment groups and eye score and pathogen load 
summed across left and right eyes.  
Quantifying Tolerance 
Point tolerance offers a snapshot of disease severity by comparing peak host 
pathology to peak pathogen burden (Little et al. 2010). It is often presented as a slope such 
that shallower slopes represent more tolerant hosts. However, when subjects start at a 
common baseline (0 pathogen load, 0 pathology, as in our study), comparing slopes that pass 
through the origin and the infection peak is analogous to simply comparing peak maxima 
among groups. To assess resistance in this context, we first fit a linear model for peak 
pathogen load by treatment as a fixed effect. We then fit a linear mixed-effects model for 
peak pathology using time (baseline versus peak), treatment, and their interaction as fixed 
effects with a random effect for bird ID. We again used Tukey pairwise comparisons to 
evaluate contrasts. 
As an alternative to point tolerance, we created a metric to yield a more continuous 
range of values for pathology and pathogen load, akin to range tolerance (described in Little 
et al., 2010). Specifically, we calculated discrete integrals of pathogen load (log10) and 
pathology over time for each individual. We estimated the area under each curve using a 
series of polygons for which the width equaled the number of days between samples and the 
height was assumed to change linearly between each time point. Because we collected eye 
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scores three times per week and pathogen load only once per week, this method generated a 
more fine-scale approximation for pathology (12 polygons in experiment 1 and 11 in 
experiment 2) than pathogen load (4 polygons). Of note, we excluded days 0-3 from the 
integrals of pathogen load as we did not sample the eyes immediately after inoculation and so 
did not have a value for pathogen load at this time (day 0). To evaluate range tolerance, we 
then fit a linear model for the integrals of pathology on the squared integrals of pathogen load 
(log10), allowing slopes to vary by treatment, but with intercepts constrained to the origin. 
We then compared slopes such that shallower slopes were consistent with higher range 
tolerance over time. 
Results 
Experiment 1: Tolerance Induction Study 
Pathology 
Eye pathology, measured by sum eye score, showed patterns typical of MG infection, 
increasing and then resolving over the course of 28 days (Figure 2.3a, LMM: DPI: F12,300 = 
21.67, p < 0.01). NSAID therapy reduced overall pathology (treatment: F2,25 = 5.29, p = 0.01; 
treatment x DPI: F24,300 = 1.58, p = 0.04) and resulted in earlier resolution of clinical signs. 
On average, maximum sum eye scores occurred on day 7 in meloxicam-treated birds, day 10 
in flurbiprofen-treated birds, and day 12 in control birds (Figure 2.3a). Tukey pairwise 
comparisons indicate that eye scores among NSAID treated birds first diverged from controls 
early in the disease cycle (meloxicam, day 10: p = 0.02; flurbiprofen, day 12: p < 0.01), with 
mean pathology reduced by over 2 eye scores at maximum contrast with controls. Treated 
birds continued to show lower pathology through day 19 on meloxicam (p < 0.02) and day 24 
on flurbiprofen (p < 0.04).  
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Figure 2.3  In experiment 1, NSAID treatment significantly reduced the severity of 
conjunctivitis (a) among house finches infected with MG. Pathogen load (b), however, did 
not significantly differ between non-NSAID treated birds (controls) and meloxicam-treated 
birds, while flurbiprofen-treated birds showed reduced pathogen loads by day 14 of 
infection. Points show group means plus 1 standard error. 
Pathogen load 
The log10 values of pathogen load, summed across both eyes, showed a peak after 
experimental infection followed by a gradual decline over the study period (Figure 2.3b, 
LMM: DPI: F5,125 = 261.24, p < 0.01). Though all treatment groups peaked at ~106 copies of 
MG DNA (Figure 2.3b), pathogen load did differ across treatment groups (treatment: F2,25 = 
4.93, p = 0.02; treatment x DPI: F10,125 = 1.71, p = 0.08). Specifically, flurbiprofen-treated 
birds split from control birds on day 14, then reduced burdens by over an order of magnitude 
through day 28 (Tukey pairwise comparisons, all p ≤ 0.01). Pathogen load among 
meloxicam-treated birds did not differ from control birds during this time (p > 0.12).  
Point tolerance 
We evaluated point tolerance using peak pathology and peak pathogen load (see 
“Quantifying tolerance” under “Methods”). Though all groups reached a similar peak 
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pathogen load (LM: treatment: F2,25 = 2.75, p = 0.08), it evoked different host responses 
among treatment groups, as quantified by peak pathology. NSAID-treated birds showed 
enhanced point tolerance to MG infection (Figure 2.4a; LMM: time x treatment: F2,25 = 
11.18, p < 0.01), such that the control group developed higher peak pathology than either the 
meloxicam (contrast: estimate = -1.79, t = -5.71, p < 0.01) or flurbiprofen treatment groups 
(contrast: estimate = -1.79, t = -5.71, p < 0.01). Control birds exhibited severe pathology, 
with a mean peak score >5, and 5/10 birds scoring a 6 (the maximum possible). NSAID-
treated birds clearly diverged from the control group, with maximum eye scores closer to 3 
(meloxicam: mean 3.3, flurbiprofen: mean 3.4).  
 
Figure 2.4  NSAID treatment resulted in lower peak pathology per peak pathogen load, 
consistent with point tolerance (a) among house finches experimentally infected with MG in 
experiment 1. Meloxicam treatment also resulted in greater range tolerance to infection, 
indicated by the shallower slope between the integrals of pathogen load and pathology (b). 
Points in (a) show group means ± 1 standard error. Points in (b) represent individual birds, 





We found that a quadratic function achieved the best fit to the data, such that the 
integral of pathology varied by the square of the integral of pathogen load (Figure 2.4b; see 
“Quantifying tolerance” under “Methods”). Slopes differed among treatment groups (LM: 
F3,24 = 82.87, p < 0.01), with meloxicam treatment producing a shallower slope than the 
control, consistent with range tolerance (contrast: estimate = 0.002, t = 2.79, p = 0.03). 
Of note, a simplified linear model with treatment removed performed worse than the 
full model (∆AICc = 2.37), supporting an effect of treatment on range tolerance. 
Antibody response 
As expected, all birds started with low antibody titers consistent with no prior 
exposure to MG. Titers peaked around day 14, then fell as birds began to recover (Figure 2.5, 
LMM: DPI: F2,50 = 43.52, p < 0.01). NSAID treatment had a limited main effect on titer 
values (treatment: F2,25 = 3.07, p = 0.06; treatment x DPI: F4,50 = 1.10, p = 0.37), with the 
strongest antibody response in the control group, the weakest response in the meloxicam 
group, and an intermediate response in the flurbiprofen group (Figure 2.5). On day 14, 
meloxicam-treated birds produced significantly lower titers than control birds (contrast: 
estimate = -0.096, t = 2.74, p = 0.03), with no difference by day 28. Titers from flurbiprofen-
treated birds did not differ significantly from controls at any point. 
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Figure 2.5  Levels of circulating anti-MG IgY antibodies varied by NSAID treatment 
following experimental infection with MG in experiment 1. Specifically, control birds 
produced the highest titers, flurbiprofen-treated birds produced intermediate titers, and 
meloxicam-treated birds produced the lowest titers. Points show group means plus 1 
standard error. 
Experiment 2: Critical Window Study 
Pathology 
Eye pathology was generally milder in experiment 2, despite using the same source 
population of birds and dose and strain of inoculum. Eye scores peaked on day 10 and then 
incrementally decreased as birds recovered (Figure 2.6a, LMM: DPI: F11, 295 =14.82, p < 
0.01). Though the 7-day treatment group experienced higher mean eye scores, we found high 
variance around group means and failed to detect a treatment effect on clinical outcomes 
(treatment: F3, 27 = 1.70, p = 0.19; treatment x DPI: F33, 295 = 0.93, p = 0.58). 
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Figure 2.6  Eye score (a) and pathogen load (b) did not significantly differ across NSAID 
treatment groups in experiment 2, though 7-day birds experienced worse conjunctivitis 
during late infection. Points show group means plus 1 standard error. 
Pathogen load 
Pathogen load peaked for all groups between days 3 and 7, followed by a steady 
decline (Figure 2.6b, LMM: DPI: F5,134 = 225.31, p < 0.01). We did not detect an overall 
effect of treatment on pathogen load in this study (treatment: F3,27 = 2.15, p = 0.12; treatment 
x DPI: F15,134 = 1.17, p = 0.30). However, the control group maintained the lowest pathogen 
load at all time points, differing by 1-2 orders of magnitude from all NSAID treatment 
groups on days 14, 28, and 38. Notably, on day 14, the control group had significantly lower 
bacterial burdens than both the 3-day (contrast: estimate = -1.97, t = 3.26, p = 0.01) and 7-
day (contrast: estimate = -1.69, t = 2.90, p = 0.03) treatment groups. Control burdens were 
also marginally lower than those of 7-day birds on day 28 (contrast: estimate = -1.54, t = 





Peak pathogen load did not differ across treatment groups (LM: treatment: F3,27 = 
1.67, p = 0.20). Although we did not find an overall effect of treatment on point tolerance 
(Figure 2.7a; LMM: time x treatment: F3,27 = 2.00, p = 0.14), 7-day birds showed higher peak 
pathology than either control (contrast: estimate = -1.63, t = 2.73, p = 0.05) or 28-day birds 
(contrast: estimate = 1.88, t = 3.16, p = 0.02). The 7-day treatment group had a mean peak 
eye score of 4.13, with 3 birds scoring a 6 and 7/8 birds scoring >3. In contrast, the control 
group had a mean peak score of 2.50 with no birds scoring a 6 and only 2/8 birds scoring >3, 
the 3-day treatment group had a mean of 3.21 with 1 bird scoring a 6 and 3/7 birds scoring 
>3, and the 28-day treatment group had a mean of 2.25 with 1 bird scoring a 6 and 2/8 birds 
scoring >3.  
Figure 2.7  In experiment 2, NSAID treatment did not reduce peak pathology per peak 
pathogen load indicative of point tolerance. However, the 28-day treatment group did show 





We evaluated range tolerance again using a quadratic function whereby the integral of 
pathology varied by the square of the integral of pathogen load (Figure 2.7b). Slopes differed 
among treatment groups (F4,26 = 33.87, p < 0.01), with the 28-day treatment group showing 
the greatest range tolerance. However, only the slopes for the 7-day and 28-day treatment 
groups produced a significant contrast (estimate= -0.002, t = -2.87, p = 0.04).  
Of note, a simplified linear model with treatment removed performed as well as the 
full model (∆AICc = 0.33), suggesting no strong effect of treatment on range tolerance. 
Antibody response 
Titers for all groups peaked around day 14, then fell as infection resolved (LMM: 
DPI: F3,80 = 26.01, p <0.01). Of note, one bird in the control group showed markedly elevated 
titers on day 38, despite declining pathogen load that plateaued on day 28 at ~101 copies of 
MG DNA. This explains the mean rise in the control titer on day 38 (Figure 2.8). Although 
the 7-day treatment group did not produce the highest titers, its titers remained elevated in 
late infection, like its eye pathology, despite pathogen burdens on par with other groups. The 
28-day treatment group generally maintained the lowest antibody titers over the course of 
infection. However, overall treatment did not have a major fixed effect on antibody 
production (treatment: F3,28 = 0.32, p = 0.81; treatment x DPI: F9,80 = 0.89, p = 0.54). 
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Figure 2.8  Levels of circulating anti-MG IgY antibodies did not significantly differ across 
NSAID treatment groups in experiment 2. Points show group means plus 1 standard error. 
Discussion  
The current studies used chemotherapeutics to evaluate whether modulating the pro-
inflammatory response to infection could enhance host tolerance in a model wildlife disease 
system, finch mycoplasmosis. We hypothesized that exogenous treatment with non-steroidal 
anti-inflammatory drugs (NSAIDs) would significantly reduce conjunctival pathology, 
shifting the host response toward tolerance (reduced pathology for a given pathogen load). 
Though birds reached similar peak pathogen loads across studies (~106 copies MG DNA), 
NSAID treatment produced mixed results, with treated birds developing milder eye lesions 
than control birds during the tolerance induction study but not the critical window study. 
However, subtle consistencies in the patterns from both studies support a role for 
inflammatory responses underlying disease phenotype in this system. 
In the tolerance induction study, birds treated daily with topical or systemic NSAIDs 
experienced lower and earlier peak pathology, with most birds peaking by day 7. We 
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hypothesized that if the events of early infection determine peak pathology, then we could 
induce tolerance by restricting NSAID treatment to this “critical window.” However, in the 
critical window study, birds that received NSAID treatment through day 3 or 7 of infection 
appeared to experience higher peak pathology, resulting in decreased point tolerance (Figure 
2.7a). This discrepancy between studies may be an artifact of small sample size and random 
assortment, rather than actual treatment effects, as 3- and 7-day NSAID-treated birds began 
to diverge from 28-day birds prior to any discontinuation of treatment (Figure 2.6a).  
In addition, birds in the critical window study received anti-protozoal prophylaxis 
(dimetridazole) for trichomonosis, which birds in the tolerance induction study did not. 
Though such protozoal infections can elicit a similar pro-inflammatory response as 
mycoplasmal infections, it is unlikely that differences in trichomonad coinfection or 
dimetridazole treatment led to the observed differences between studies. First, Anderson et 
al. 2009 found that trichomonosis caused high mortality (>95%) in house finches. It is 
therefore unlikely that birds in the tolerance induction study could have survived coinfection, 
such that we recorded exaggerated inflammation as a result of fulminant trichomonosis. 
Moreover, dimetridazole acts by specifically inhibiting DNA synthesis in the pathogen 
(Moreno and Docampo, 1985), meaning we would not expect treatment to influence host-
mediated inflammation. 
However, differences between the tolerance induction and critical window studies 
may have been accentuated by high baseline levels of tolerance in the population from which 
these birds were captured. Recent work suggests that finches from Iowa show comparable 
tolerance to MG infection as finches from Virginia (where the pathogen emerged) and higher 
tolerance than finches from either Arizona or Hawaii (where the pathogen has a limited 
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distribution or has not been detected) (Henschen et al. unpublished). In other words, if 
tolerance is already high in our source population, suppressing residual inflammation with 
NSAIDs may not yield a consistent, quantifiable effect. 
Still, in both studies we found that long-term NSAID treatment enhanced range 
tolerance. Specifically, the meloxicam treatment group in the first study and the comparable 
28-day meloxicam treatment group in the second study both showed higher range tolerance 
than the positive control birds (Figures 2.4b, 2.7b). In the tolerance induction study, birds 
experienced milder clinical signs despite comparable bacterial burdens over the course of 
infection, yielding a shallower slope in the phase plot for range tolerance (Figure 2.4b). In 
contrast, during the critical window study, the 28-day birds showed similar pathology as 
control birds, but elevated pathogen loads during late infection, yielding a shallower slope for 
range tolerance (Figure 2.7b). Taken together, these data suggest that daily NSAID treatment 
enhanced phenotypic tolerance to finch MG across both studies, but through slightly different 
mechanisms: reducing peak and overall pathology in the first study and damping pathogen 
clearance during the second study. 
We also consistently measured the lowest antibody levels in these long-term 
meloxicam treatment groups (Figures 2.5, 2.8). Hosts from a wide array of taxa take roughly 
two weeks to produce pathogen-specific antibodies as part of the adaptive immune response, 
with IgY antibodies forming the primary isotype in birds (Härtle et al., 2014). In the 
tolerance induction study, meloxicam-treated birds, produce a significantly lower mean titer 
than the control group on day 14 (p = 0.03, Figure 2.5). Because NSAIDs can dampen the 
same danger signals that recruit innate immune cells to the site of tissue injury (Tabas and 
Glass, 2013), control birds likely experienced a stronger innate immune response, facilitating 
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robust B-cell activation and antibody production. The pattern observed in the NSAID-treated 
groups should therefore reflect degrees of innate immune suppression, mediated by reduced 
pro-inflammatory signaling. Whereas flurbiprofen functions locally, meloxicam can reduce 
the propagation of inflammatory signals and immune activation systemically. Therefore, we 
would expect meloxicam treatment to exert the greatest effect on B-cell activation (lowest 
IgY titers), consistent with our findings.  
Yet in the critical window study, the 28-day meloxicam group experienced 
comparable pathology despite producing lower mean IgY titers and maintaining higher 
pathogen loads than controls. Though pathogen clearance slowed during late infection, it did 
not cease, suggesting that the humoral response may have still exceeded a minimum 
threshold needed for effective protection. In natural infections, the rise in antibody titer 
generally reflects the amount of antigen being sampled by immune cells (Gray, 2002; Grodio 
et al., 2012), but antibody production may be relatively inexpensive for passerines (Svensson 
et al., 1998). If finches commonly produce a surplus of antibodies to infectious challenge, 
then NSAID treatment may have reduced it here without impacting clearance. Alternatively, 
our results might indicate that we are not measuring the most salient metric of adaptive 
immunity for pathogen clearance, in which case future work should consider other antibody 
isotypes like IgA, which is mucosa-associated (Grodio, Buckles and Schat, 2009), as well as 
the role of cell-mediated immunity in MG resistance. 
Finally, we targeted the COX pathway in these studies using a fairly conservative 
NSAID dosing regimen. Though higher or more frequent doses of meloxicam have been 
reported in the literature, they have not been evaluated for long-term treatment up to several 
weeks duration (Sinclair et al., 2012; Dijkstra et al., 2014). We must also consider how this 
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might increase handling time and stress, which could in itself change disease outcomes 
without developing more discrete methods of delivery, such as medicated water. Regardless 
of approach, increasing the treatment dose could better control for individual variation. Then 
again, it is plausible that other chemotherapeutic regimes can more effectively modulate 
disease tolerance. For instance, corticosteroids dampen inflammation by acting on molecules 
further upstream of those targeted by NSAIDs (Clark-Price, 2013). However, because of 
their broad, systemic effects on host physiology, interpreting the effects of corticosteroid 
treatment on infection can prove challenging. 
Nevertheless, even naturally occurring variation in this system suggests that key 
events during early infection can set hosts on vastly different disease trajectories. Birds that 
experienced more severe disease outcomes tended to show higher eye scores during the first 
week of infection. These observations lend support to our critical window hypothesis, even if 
we were unable to consistently manipulate early inflammation through the COX pathway. If 
peak pathology is determined by the extent of inflammation during MG colonization and 
establishment, there should be strong selection in the wild favoring tolerance during early 
infection to maintain host fitness. Documenting natural variation in early inflammatory 
responses among wild populations, and comparing resultant pathology to that of NSAID-
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Flurbiprofen Treatment Effects 
 
Flurbiprofen treatment was administered unilaterally via eye drop such that each bird had a 
treated and untreated eye. Neither pathology (a) nor pathogen load (b) significantly differed 










CHAPTER 3.    DISEASE TOLERANCE ALTERS HOST COMPETENCE IN A 
WILD SONGBIRD 
Introduction 
Host competence, or the ability to transmit pathogens to others, is highly variable 
across individual animals (Gervasi et al., 2015; Martin et al., 2016; Burgan et al., 2019; 
Martin et al., 2019). This variation can alter the persistence and magnitude of disease 
outbreaks (Lloyd-Smith et al., 2005; Vale, Fenton and Brown, 2014; Hall, 2019), so 
understanding its underlying causes could be crucial for predicting or mitigating epidemics in 
the wild. One obvious driver of host competence is the amount of pathogen available to 
infect others, but more subtle aspects of an individual’s clinical presentation, or disease 
phenotype, may also regulate its potential to expose conspecifics. For example, tolerance 
describes a spectrum of disease phenotypes that reflect reductions in the per-pathogen costs 
of infection on host fitness (Råberg, 2014). Because tolerant animals experience fewer 
deleterious impacts of disease, they may come into more frequent contact with susceptible 
hosts and fomites while infectious. As such, several authors have suggested that tolerant 
hosts should be more competent (Martin et al., 2016; Martin et al., 2019). However, because 
clinical signs often aid transmission (e.g. coughing) and tolerant animals experience milder 
disease, these hosts may prove less capable of shedding, and thus spreading, disease. As a 
result, other authors have postulated that tolerant hosts should be less competent (Adelman 
and Hawley, 2017; Henschen and Adelman, 2019). Here we test whether these contrasting 
predictions can be reconciled by deconstructing disease tolerance into two core components 
and then evaluating their effects on pathogen transmission. 
To do so, we break tolerance into tissue-specific and behavioral components by 
measuring separate but related responses to infection: pathology and sickness behaviors 
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(Adelman and Hawley, 2017). Pathology describes the immediate costs of infection due to 
pathogen-induced tissue damage, perhaps compounded by host-mediated immunopathology 
(Råberg, Graham and Read, 2009), whereas sickness behaviors capture the opportunity costs 
of becoming diseased and diverting energy toward pathogen defense (Johnson, 2002). By 
reducing the magnitude of pathology, tolerant hosts minimize losses in function and fitness 
caused by infection (Medzhitov, Schneider and Soares, 2012). Similarly, by expressing fewer 
sickness behaviors, tolerant hosts can allocate their time toward fitness-enhancing activities, 
like foraging or mate-finding (Adelman and Hawley, 2017). To evaluate how tissue-specific 
and behavioral tolerance might change host competence, we can think of tolerance along a 
continuum of disease phenotypes and then compare those phenotypes at either extreme. 
For example, low tissue-specific tolerance manifests as severe pathology and a 
worsening of clinical signs that may facilitate exposure to conspecifics. For example, with 
respiratory pathogens like influenza A, damage to the target tissues enhances coughing, 
which in turn propagates infectious droplet nuclei required for transmission (Cowling et al., 
2013). Yet, severe pathology can prove debilitating to the host, impeding the normal form 
and function of the affected tissues (i.e. hypoxia, respiratory failure, or death). By 
comparison, high tissue-specific tolerance will produce milder clinical signs due to pathology 
and increased survival, with lower pathogen loads shed over a longer transmission window 
(VanderWaal and Ezenwa, 2016). As long as reducing pathology does not prevent 
transmission, tolerant hosts should accumulate more opportunities to transmit pathogen, 
enhancing host competence (Adelman and Hawley, 2017; Henschen and Adelman, 2019). 
However, if pathology is essential to shedding pathogen and exposing conspecifics, then 
tolerant hosts should be less effective transmitters of disease, reducing host competence 
38 
(Vale, Fenton and Brown, 2014; Adelman and Hawley, 2017; Henschen and Adelman, 
2019). 
By contrast, low behavioral tolerance manifests as a greater expression of sickness 
behaviors like lethargy and anorexia. When expressed at moderate levels, such behaviors 
may conserve energy and divert resources toward pathogen eradication and tissue repair 
(Hart, 1988; Johnson, 2002). But, severe sickness behaviors can decrease short-term survival, 
by keeping hosts from adequately provisioning or avoiding predators, as well as long-term 
fitness, by preventing hosts from defending territories, securing mates, or caring for young 
(Adelman and Hawley, 2017). As with influenza A, if an individual restricts contact with its 
social network due to severe fatigue, it can break the transmission cycle. In contrast, high 
behavioral tolerance should reduce the expression of sickness behaviors, allowing more time 
for fitness-enhancing behaviors like foraging and associating with conspecifics (Adelman 
and Hawley, 2017). Therefore, tolerant individuals should maintain higher contact rates with 
potential new hosts, increasing host competence (Hawley et al., 2011a; VanderWaal and 
Ezenwa, 2016; Adelman and Hawley, 2017). 
Here we explore the effects of tissue-specific and behavioral tolerance on host 
competence using an ecologically relevant disease system, house finches (Haemorhous 
mexicanus) infected with the bacterial pathogen Mycoplasma gallisepticum (MG). Finch MG 
first emerged in songbirds in the early 1990s and presents as conjunctivitis of varying 
severity in house finches, the predominant host species (Ley, Berkhoff and McLaren, 1996). 
Several aspects of house finch life history appear to drive the ecology of this disease, notably 
finches’ close association with bird feeders (Altizer, Hochachka and Dhondt, 2004; Dhondt 
et al., 2007; Adelman et al., 2015). Feeders congregate birds and act as fomites in this 
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system, and therefore play a critical role in the transmission pathway (Dhondt et al., 2007; 
Adelman et al., 2015). 
Accordingly, this system is an excellent model for examining how tissue-specific and 
behavioral tolerance alter disease spread. First, because pathology enhances pathogen 
deposition onto bird feeders (Adelman et al., 2013a), we can predict that tissue-specific 
tolerance will reduce host competence in this system. In particular, infected animals with less 
pathology (higher tissue-specific tolerance) should shed less pathogen onto bird feeders, 
impeding transmission (Vale, Fenton and Brown, 2014). Second, because infected house 
finches that spend more time on bird feeders are more likely to transmit the pathogen to 
conspecifics (Dhondt et al., 2007; Adelman et al., 2015), we can predict that behavioral 
tolerance will increase host competence in this system. Specifically, infected animals 
expressing milder sickness behaviors (higher behavioral tolerance) should visit feeders more 
often, enhancing a critical transmission pathway. We evaluated these predictions by 
simulating epidemics in co-housed pairs of house finches, experimentally inoculating one 
bird (the index case) and monitoring time to transmission in its cage-mate. We then 
calculated metrics of tissue-specific and behavioral tolerance for the index birds and modeled 





We captured house finches between 6 July and 17 September, 2017 using mist nets 
set up around bird feeders in Ames, Iowa. We used plumage patterns to identify and retain 
hatch-year birds, the age-class least likely to have prior pathogen exposure (Pyle, 1997). 
Collection permits were obtained from the Iowa Department of Natural Resources (SC1133), 
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the U.S. Geological Survey Bird Banding Lab (23952), and the U.S. Fish and Wildlife 
Service (MB82600B-1), and all procedures were approved by Iowa State University’s 
Institutional Animal Care and Use (7-16-8311-Q) and Biosafety Committees (17-I-0021-A). 
Initial Housing and Quarantine 
 
Birds were transported to a Laboratory Animal Resources facility at Iowa State 
University in single-use paper lunch bags. Upon arrival, birds received an aluminum 
numbered band on the right tarsometatarsus and were dusted birds with GardenTech Sevin-5 
Ready-To-Use 5% Dust (TechPac, LLC., Atlanta, GA) to remove ectoparasites. They then 
entered a minimum two-week quarantine period in individual cages (76 cm x 46 cm x 46 
cm), with ad libitum access to water and a 20:80 mix of black oil sunflower and safflower 
seeds and food pellets (Daily Maintenance Nibbles, Roudybush, Inc., Woodland, CA), grit, 
and cuttlebone.  
Due to unexpected mortality, all birds received a five-day prophylactic course of 
dimetridazole (Cankerex Plus, Medpet, Benrose, South Africa) treatment at a dilution of 
0.025% in their drinking water. Birds were monitored for clinical signs of MG infection (eye 
pathology) every three days. On day 14-15, we collected blood (<75 µL) from the ulnar 
(wing) vein to screen for anti-MG IgY antibodies using a modified protocol with a 
commercially available ELISA test kit (Cat # 99-06729, IDEXX Laboratories, Inc., 
Westbrook, ME, validated in Grodio, Buckles and Schat, 2009). Any birds with a 
sample:positive (S/P) ratio > 0.0229 on light spectroscopy were considered positive for 
previous MG exposure (Hawley et al., 2011b), and thus deemed ineligible for our study. 
Infected or exposed birds were released back into the wild at their site of initial capture. 
Finches that passed the quarantine period were moved into 16 mixed-sex flocks of three birds 
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each, housed in cages measuring 76 cm x 46 cm x 91 cm (see also “Flock Transmission 
Study,” below).  
Transition to Tube Feeders 
 
Once in the three-bird flocks, we transitioned animals from cup feeders to hanging 
tube feeders over a two-week period via intermittent but increasing exclusion of cup feeders 
each day. Birds were carefully monitored during this period using video to ensure all 
individuals were eating. The addition of masking tape to perch surfaces facilitated feeder use 
in two cages, and no further intervention was necessary. To facilitate MG transmission 
during experiments, we blocked one of the two available feeding ports using an electrical 
outlet safety plug secured with duct tape.  
Initial Video Recordings 
Each cage was fitted with a YI action camera (YI Technology, Bellevue, WA) so we 
could record activity at the tube feeder. To determine pre-infection feeding behavior, we 
completed one-hour focal surveys of video from each group and ranked individuals by the 
frequency of their feeding bouts. We selected birds holding the same relative feeding rank for 
experimental inoculation, allowing us to standardize for feeding intensity as a potential 
source of variation in transmission rate (Adelman et al., 2015).  
Transmission Studies 
Flock experiment 
Prior studying MG transmission in pairs of finches, we attempted a similar study 
using the above flocks that resulted in a single transmission event. Here we briefly report the 
methods of the flock transmission experiment, as all birds involved in the paired experiment 
were recruited from this first study. The three-bird flock transmission experiment ran 21 
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October-16 November 2017 (27 days). Birds were housed in large group cages (76 cm x 46 
cm x 91 cm) placed on individual metal racks positioned around the periphery of three 
separate rooms, with no overlap between racks. We further attached clear plastic curtains to 
the sides of each rack to minimize the risk of cross-cage transmission. In addition, each 
experimental infection room contained a sentinel bird (n = 3) that remained singly housed in 
a smaller cage (76 cm x 46 cm x 46 cm) to surveil for cross-cage MG exposure. Sentinels 
shared the same racks as flocks but were placed on a shelf directly above. Laboratory Animal 
Resources staff were instructed to care for all sentinels before interacting with flocks. We 
also sampled sentinels before handling flocks to prevent accidental exposures. 
The three-bird flocks consisted of one experimentally-infected “index” case and two 
“non-index” flock-mates. Based on initial video recordings of feeding frequency, the mid-tier 
feeder was selected as the index case for all flocks. Of these index cases, half (n = 8) received 
meloxicam at 1 mg/kg/day (0.5 mg/mL oral suspension; Boehringer Ingelheim, Ridgefield, 
CT) and half (n = 8) received water at 2 mL/kg/day for comparable treatment volumes 
beginning one day prior to inoculation (day -1). Our previous work initially suggested that 
meloxicam could reduce the clinical signs (conjunctivitis) caused by MG infection without 
changing peak pathogen load, thererby enhancing tissue-specific tolerance (Chapter 1). On 
experimental day 0, index birds were experimentally-inoculated with 25 µL containing 1.88 
x 105 CCU of a mild finch MG isolate (‘VA1994,’ stock ID 7994-1-7P 2/12/09; D. H. Ley, 
North Carolina State Univ., College of Veterinary Medicine, Raleigh). Flocks were 
monitored for 27 days, however transmission was rare. Across 16 flocks, seven birds from 6 
flocks became seropositive for MG exposure, and only one bird developed clinical signs 
consistent with MG infection.  
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Pairs experiment 
Following the flock experiments, 24 non-index birds that showed no clinical or 
serological signs of MG exposure were recruited into a second transmission study using pair-
housed birds. Existing flock-mates were transferred to smaller cages (76 cm x 46 cm x 46 
cm), and formerly single-housed birds (sentinels) were reassigned partners of the opposite 
sex, when possible, for a total of 12 pairs. As in the flock experiment, each pair had its own 
rack with plastic curtains to minimize the risk of cross-cage exposure. To increase the odds 
of transmission, we chose the bird that fed more often as the index case, using either relative 
flock-rank for prior flock-mates or baseline feeding frequency for new pairs. Half of these 
index birds (n = 6) received 1 mg/kg/day oral meloxicam and half (n = 6) received 
2mL/kg/day oral water, starting two days prior to experimental inoculation (day -2) and 
continuing 21 days post-inoculation. Treatments were chased with 100 µL of water to 
encourage birds to swallow.  
To further increase the probability of transmission in this experiment, we used a more 
virulent isolate of finch MG: ‘NC2006’ (stock ID 2006.080-5(4P) 7/26/12). On 11 
December, 2017 (experimental day 0), a volume of 25 µL containing 6.25 x 104 color-
changing units (CCU) was applied to each eye via micropipette, with birds maintained in 
horizontal recumbency until the fluid dissipated below the eye rim. During infection, we 
recorded pairs weekly and used scan sampling to log feeding frequency during one-hour 
segments beginning 5 minutes after lights turned on (0600h). For every minute of video, we 
completed two 10s scans separated by 20s. For each scan, birds were assigned a “0” if they 
did not feed or a “1” if they fed at least once. 
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Sampling, Polymerase Chain Reaction, and Serology 
We monitored non-index birds for signs of transmission via eye scores and 
conjunctival swabs. All birds (index and non-index) were scored 3x per week for 3 weeks, 
then 2x per week for 3 weeks using a four-point scale from 0 (no pathology) to 3 (severe 
pathology) (Sydenstricker et al., 2006). We further characterized eye lesions according to the 
presence of the following pathological descriptors: blepharospasm, crusting, erythema, 
eversion, exudate, and swelling. Conjunctival swabs were collected from non-index birds 2x 
per week for 3 weeks, then 1x per week for 3 weeks to evaluate for the presence of MG 
DNA. Conjunctival swabs were also collected from index birds 1x per week throughout the 
study. To collect conjunctival swabs, we used sterile forceps to abduct the lower eye rim, 
followed by insertion of a sterile cotton-tipped applicator dipped in tryptose phosphate broth 
(TPB) and rotated for 5s. Samples were pooled by bird, meaning that swabs from each eye 
were rung out into a single microcentrifuge tube containing 300 µL TPB. Samples were then 
stored at -20°C until extraction using the Qiagen DNEasy Blood and Tissue kit (Cat no. 
69504/69506, Qiagen, Valencia, CA). Finally, we used quantitative polymerase chain 
reaction (qPCR) to measure pathogen load by targeting the mgc2 gene, which encodes a 
well-described cytadhesin-like protein. Conditions and primers followed those previously 
described in (Grodio et al., 2008). Blood samples were collected from all birds on days 14, 
30, and 44, immediately centrifuged to separate the plasma, then stored at -20°C for later 
serological evaluation with ELISA. Lastly, behavior was recorded for each pair 1x/week for 






We calculated tolerance slopes for each index case using pre-infection data and data 
collected within a transmission window specific to each pair. This window began with 
inoculation on experimental day 0 and ended on the day pathology was first detected in the 
naïve cage-mate. For pairs that showed no transmission, we defined the end of the window 
by the full length of the study (43 days).  
Using these data, we calculated the slope of tissue-specific tolerance as the change in 
pathology over the change in pathogen load. Index birds started without measurable 
pathology so the change in pathology reflected the maximum eye score observed during the 
transmission window. The change in pathogen load was calculated as peak pathogen load 
minus the pathogen load measured prior to the start of the pair experiment. Pathogen was 
absent or undetectable in 6/12 index birds when this study began. The highest pre-infection 
pathogen load among index birds was 102 copies of the mgc2 gene, consistent with the 
potential for some prior exposure or environmental contamination. 
We calculated the slope of behavioral tolerance as the change in feeding frequency 
over the change in pathogen load. Specifically, we measured the proportion of time index 
birds spent feeding on days 3, 10, and 17 post-inoculation. We then subtracted the pre-
inoculation value from the lowest value observed during the first 17 days post-inoculation or 
until the time of transmission. Most birds reduced their feeding frequency by day 10 and then 
recovered, though one index bird experienced its lowest feeding frequency on day 17. The 
change in pathogen load was calculated as described above. 
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Model selection for survival analysis 
To test how time to transmission varied with tissue-specific and behavioral tolerance, 
we ran accelerated time failure models using package ‘survival’ (Therneau and Grambsch, 
2000; Therneau, 2015) in R, version 3.5.2 (R Development Core Team, 2018). The initial, 
maximal model included the following five independent variables: the slopes for tissue-
specific and behavioral tolerance, the maximum pathogen loads detected during the flock 
study for either index birds or naïve cage-mates, and the meloxicam treatment status of the 
index bird. All parameters were normalized by z-score (mean = 0, standard deviation = 1) to 
allow direct comparison of effect sizes. We first fit five versions of this maximal model with 
different error distributions (Weibull, logistic, lognormal, loglogistic, and exponential), 
selecting loglogistic as the best fit using Akaike’s Information Criterion adjusted for small 
sample sizes (AICc) (Burnham and Anderson, 2002). We then used model selection to derive 
the best-fit model from a series of simplified models. To avoid variance inflation from 
multicollinearity, we did not fit models with pairs of independent variables whose Spearman 
rank correlation exceeded a conservative 0.5 (Freckleton, 2011). This yielded a set of 15 
competing models. 
Results 
 The most competitive accelerated time failure model contained three independent 
variables: the slope for tissue-specific tolerance, the slope for behavioral tolerance, and the 
maximum pathogen load detected in index cases during the flock study. Two other models 
scored within 2 ∆AICc units, both of which contained tolerance slopes as predictors (Table 
3.1). 
The top model found that birds with higher tissue-specific tolerance (less pathology) 
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took longer to transmit pathogen to their cage-mates (estimate = 0.57, z = 4.77, p <0.01; 
Figure 3.1a), whereas birds with higher behavioral tolerance (milder sickness behaviors) 
transmitted pathogen more quickly (estimate = -0.55, z = -2.97, p <0.01; Figure 3.1b). The 
magnitude of prior MG exposure in the index case also predicted a shorter time to 
transmission, however this effect appeared to be driven by a single index bird (estimate = -
0.33, z = -4.32, p < 0.01; Figure 3.1c).  
Table 3.1  The top two models of time to transmission included both tolerance slopes as 
predictors. The slope of tissue-specific tolerance was a predictor in all top five models. 
 
Model Predictors AICc ΔAICc Weight 
1 
Tissue-specific Tolerance, Behavioral 
Tolerance, Index Bird Maximum Pathogen 
Load (Prior Study) 
63.1 0.0 0.42 
2 Tissue-specific Tolerance, Behavioral Tolerance 64.1 1.0 0.26 
3 Tissue-specific Tolerance 64.9 1.8 0.17 
4 Tissue-specific Tolerance, Index Bird Maximum Pathogen Load (Prior Study) 65.5 2.4 0.13 
5 Tissue-specific Tolerance, Index Bird Meloxicam Treatment 69.2 6.1 0.02 
 
 
Figure 3.1  Time to transmission plotted against the independent variables retained in the 
most supported accelerated time failure model. Points represent index cases. Lines represent 
model predictions when other parameters are held constant at their means. Tissue-specific 
tolerance (a) extends the transmission window, while behavioral tolerance (b) and the 




 The present study used the natural variation in disease tolerance in a population of 
house finches to study host competence. Specifically, we dissected disease tolerance into 
tissue-specific and behavioral components and evaluated how their expression altered the 
time to transmission between infected house finches and naïve cage-mates. We predicted that 
milder pathology would impede transmission, whereas milder sickness behaviors would 
enhance transmission. Therefore, though disease tolerance mediates both tissue-specific and 
behavioral outcomes, we anticipated opposing effects on host competence.  
Consistent with our predictions, we found that birds with higher tissue-specific 
tolerance took longer to transmit pathogen. This is what we expect to see in disease systems 
like finch MG when pathology drives transmission, either through direct contact with 
conspecifics or contamination of shared resources like bird feeders (Adelman and Hawley, 
2017; Henschen and Adelman, 2019). Moreover, we see a similar reliance on pathology 
across diverse pathogen types, including macroparasitic infections when pathology can 
facilitate the completion of complex life cycles. For example, larvae of the trematode 
Ribeiroia ondatrae preferentially encyst in the hind limb buds of developing tadpoles, 
resulting in a range of pathologies at metamorphosis that make them more susceptible to 
predation by its definitive host. Johnson et al. (2012) found that species that metamorphose 
later and at larger body sizes better tolerated infection, measured as fewer limb abnormalities 
for a given parasite load. Because pathology increases the odds of transmission, we would 
expect frogs with high tissue-specific tolerance to also be less competent, as we see with 
finch MG. 
Additionally, we found that birds with higher behavioral tolerance transmitted 
49 
pathogen more quickly. Again, this is consistent with the role we would expect sickness 
behaviors to play in this disease system, diverting resources toward immune activation and 
reducing contact with other individuals and fomites (Hart, 1988; Johnson, 2002), thereby 
impeding transmission. Host behavior may similarly impact other disease systems, including 
bats infected with the fungal pathogen Pseudogymnoascus destructans (Pd), the causative 
agent of White-Nose Syndrome (WNS). Working with two North American species, Moore 
et al. (2018) found that big brown bats (Eptesicus fuscus) expressed higher behavioral 
tolerance than little brown bats (Myotis lucifugus), measured as extended bouts of torpor 
when compared to sham-inoculated controls. WNS often causes individuals to rouse more 
frequently and burn through energy reserves during hibernation. Behavioral tolerance, 
specifically prolonging torpor, may allow this slow-growing, psychrophilic pathogen to 
colonize more neighbors at a roost site. As with finch MG, this would mean that behaviorally 
tolerant hosts should also be more competent. 
Apart from the tolerance parameters, previous MG exposure also appeared to 
influence the time to transmission by index birds. We originally included this parameter to 
preclude index birds with partially protective immunity (Grodio et al., 2012) from 
confounding our results. Though all birds tested negative for anti-MG IgY antibodies on 
serology, it was plausible that exposure during the prior flock study could temper the 
expression of clinical signs during the pair study, thus hampering transmission. Yet, our 
model suggested that the magnitude of prior pathogen exposure actually shortened the time 
to transmission, a trend driven by the index case that transmitted on day 7 (Figure 3.1c). 
Though we did recover > 103 copies of MG DNA from this bird during the flock study, more 
than any other index bird, it had fewer than 10 copies by the time it entered the pair study. 
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Moreover, we recovered > 106 copies from this bird 3 days after inoculation with a markedly 
more virulent isolate, which should have swamped out any residual pathogen load. Lastly, 
because the direction of the effect is inconsistent with immune cross-protection, we would 
argue that tolerance is much more likely driving host competence in this system. 
Although pathology has often served as a proxy for fitness in the disease tolerance 
literature (Ma et al. 1998; Råberg, Sim and Read, 2007; Adelman et al., 2013b), we found 
that a more nuanced evaluation of tolerance as a multi-faceted host response can inform 
transmission dynamics. Specifically, we found opposite effects of nearly equal magnitude for 
tissue-specific and behavioral tolerance on host competence while using straightforward 
appraisals of pathology and sickness behaviors. In the future, capturing more subtle elements 
of variation in pathology (beyond relative severity) may build upon the patterns revealed here 
linking tissue-specific tolerance to transmission. Likewise, incorporating additional metrics 
of sickness behavior, like changes in sociality, may refine estimates of how behavioral 
tolerance alters pathogen spread. Still, our results suggest that incorporating both pathology 
and sickness behaviors when measuring the per-pathogen costs of disease can help us better 
evaluate the role of tolerance in precipitating or sustaining epizootics across a breadth of 
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CHAPTER 4.    USING MULTIVARIATE ANALYSES TO EXPLORE TEMPORAL 
AND EVOLUTIONARY PATTERNS IN DISEASE PATHOLOGY 
Introduction 
Many diseases that threaten wildlife populations cause external pathology, providing 
a minimally invasive, cost-effective means to assess individual health in the field. 
Researchers have developed linear, multi-point scoring systems to quantify lesion severity 
for a range of wildlife diseases including fibropapillomatosis (Work and Balazs, 1999), finch 
mycoplasmosis (Roberts, Nolan and Hill, 2001), chytridiomycosis (Obendorf, 2005), devil 
facial tumor disease (Lachish, Jones and McCallum, 2007), white-nose syndrome (Reichard 
and Kunz, 2009), and snake fungal disease (McCoy, Lind and Farrell, 2017). However, 
pathology can vary in myriad ways during a single infection, among individuals, and across 
populations (Adelman et al., 2013). So, assessing external lesions by severity scores alone 
risks overlooking important trends. Here we test multivariate methods for quantifying 
external pathology to complement a widely utilized scoring system in a common wildlife 
disease model, finch mycoplasmosis, or house finch eye disease.  
Finch mycoplasmosis is a recently emerged wildlife disease that causes severe 
inflammation of the soft tissues surrounding the globe, or conjunctiva. It is caused by 
Mycoplasma gallisepticum (MG), a bacterial pathogen of poultry that was first isolated from 
songbirds in 1994 during a sweeping die-off of house finches (Haemorhous mexicanus) on 
the East Coast of the United States (Ley, Berkhoff and McLaren, 1996; Hochachka and 
Dhondt, 2000). Scoring systems were developed soon after this pathogen’s emergence in 
finches and have been refined in the decades since (see Table 4.1; Roberts, Nolan and Hill, 
2001; Altizer, Hochachka and Dhondt, 2004; Kollias et al., 2004; Farmer, Hill and Roberts, 
2005; Sydenstricker et al., 2006; Hawley et al., 2007). Though earlier scales used more 
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comprehensive criteria, today most research groups use a four-point scale from 0 (no 
pathology) to 3 (severe pathology) with half-scores permitting 7 levels. 
Table 4.1  Comparison of the scope and specificity of eye score scales cited in the finch MG 
literature. 
 
Even the most nuanced scales (e.g., Kollias et al., 2004), however, reveal 
fundamental limitations. For instance, treating discrete eye scores like continuous data 
violates strict statistical assumptions. Additionally, the variety of scales assign different 
weights to different aspects of pathology, resulting in scores that are neither consistent nor 
reproducible across studies. This proves especially problematic in surveys evaluating the host 
response across time or populations. Finally, we lose information by collapsing complex, 
multidimensional trait space (conjunctival pathology) into a numerical score. To capture 
these differences we need new tools, introduced here, that can work with multivariate data. 
We can then use this framework to ask targeted questions relating conjunctival pathology to 
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stage of infection and host-pathogen evolution more broadly. 
Here we assess two different multivariate techniques with the potential to improve 
clinical assessment of wildlife diseases causing external pathology. First, we explore the 
unique contributions that geometric morphometrics can offer the field of disease ecology 
using finch mycoplasmosis as a model. Geometric morphometrics is a recent addition to the 
evolutionary and organismal biologists’ toolkit, combining the power of multivariate 
statistics with shape analysis (Adams, Rohlf and Slice, 2013). It was developed to capture 
geometric variation in the morphology of species or populations over evolutionary 
timescales. However, in host-pathogen systems, we can use the same methods to track rapid 
changes in host phenotype by sampling within single infections.  
Second, we apply methods from community ecology to analyze binary descriptor 
variables that capture the presence of distinct pathological phenotypes associated with finch 
mycoplasmosis. Specifically, to better characterize the breadth of host pathologies and 
capture variation in the cardinal signs of inflammation (tumor, swelling; rubor, redness; 
calor, heat; dolor, pain; and functio laesa, loss of function; see Rather, 1971), we analyze the 
presence (1) or absence (0) of the following variables: blepharospasm, crusting, erythema, 
eversion, exudate, and swelling. Blepharospasm describes squinting or blinking, which can 
enhance tear dispersal, and is used as an index for pain in veterinary ophthalmology (Barnett, 
2006). Crusting describes the accumulation of dried secretions around the eyes, as well as 
nares when rhinitis is present. Erythema describes redness and is caused by increased 
perfusion to the site of tissue injury. Eversion describes a somewhat unique pathology in 
which conjunctival tissue extends beyond the eye rim, increasing the surface area available 
for pathogen shedding. Exudate describes increased secretion of potentially infectious fluid, 
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and swelling describes expansion of the eye rim. 
We use these techniques to answer two questions regarding variation in conjunctival 
pathology caused by finch mycoplasmosis. First, we apply these techniques to paired samples 
from the same, experimentally-infected individuals, asking whether we can accurately assess 
if an individual is in the early or late stage of infection based on subtle differences in 
pathology. Then, we apply these techniques to experimental infection data from finches 
captured in different geographic regions to ask whether a population with a long history of 
MG endemism occupies a different area of morphospace or expresses a different suite of 
descriptors than one where MG is absent. Because hosts are under pressure to maintain 
fitness by minimizing all aspects of pathology, but pathogens are under intense pressure to 
enhance those pathologies likely to facilitate transmission, we predict that the population that 
has been co-evolving with MG will express a narrower range of descriptors, biased toward 
those likely to enhance shedding (exudate and eversion). In contrast, we predict that the 
population naïve to finch MG will express a broad range of descriptors, with no bias toward 
exudate and eversion. 
Methods 
Paired Specimen Study 
Technique 1: Shape Analysis 
Image acquisition and selection criteria 
Images of house finches experimentally infected with Mycoplasma gallisepticum 
(‘VA1994,’ stock ID 7994-1-7P 2/12/09; D. H. Ley, North Carolina State Univ., College of 
Veterinary Medicine, Raleigh) were collected in 2018 using an iPhone 6S (Apple, Inc., 
Cupertino, CA, USA). Size markers were affixed to stanchions projecting from the walls of 
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the lab animal facility where the birds were housed. This allowed a single observer (R. 
Ruden) to hold a bird in bander’s grip flush to the wall and take photographs, such that either 
the left or right eye was in the same plane as the size marker. Images were annotated at the 
time of collection with the bird’s identification number according to the aluminum band on 
the left or right tarsometatarsus. Day post-inoculation (DPI) was verified using dates 
retrieved from image acquisition data. Photos were collected on days 0, 5, 7, 10, 14, 17, 21, 
24, 28, 34, and 38. 
 At each time point, a separate observer (J. Adelman) scored eye pathology on a four-
point scale from 0 (absent) to 3 (severe) (Sydenstricker et al., 2006). We used the DPI that an 
individual reached its maximum eye score to define “peak” pathology. We then evaluated 
each bird’s eye score data to look for days pre- and post-peak when eyes received the same 
severity score. We extracted the corresponding images from our photo library to include as 
specimens for shape analysis.  
Landmark digitization 
We used the program tpsDIG2w32 (F.J. Rohlf, Stony Brook University, Version 
2.30) to assign landmarks to each image using a Thin-Plate Spline (.tps) overlay built in 
tpsUtil64 (F.J. Rohlf, Stony Brook University, Version 1.74). We used 16 landmarks 
delineating the inner and outer eye margins to capture conjunctival pathology (Figure 4.1). 
Landmarks were applied in the same sequence around each eye, with left eyes digitized as 
mirror images of the right so all specimens could be superimposed using package 
‘geomorph’ (Adams and Otárola‐Castillo, 2013) in R, version 3.5.2 (R Development Core 
Team, 2018). Of note, individual specimens were scaled according to a 5 mm size marker 
visible in each raw image. 
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Figure 4.1  Landmarks for right (a) and left (b) eyes assigned as mirror reflections to 
preserve landmark sequence for alignment and Procrustes superimposition in R. Landmark 
sequence defined the outer eye rim followed by the inner eye rim in a sequence that allowed 
for consistency across specimens. 
 
 Alignment, processing, and shape analysis 
 We created a matrix of semilandmark sliders to define the position of landmarks 
relative to their nearest neighbors. Specimens were then aligned by Generalized Procrustes 
Analysis (superimposition, Figure 4.2). We evaluated for fixed effects of status (a binary 
value specifying pre-peak or post-peak pathology), severity score (a categorical value from 
0-3), and their interaction on Procrustes shape coordinates using analysis of variance 
(ANOVA) on a randomized residual permutation procedure (lm.rrpp). Additionally, we ran 
principal components analysis on Procrustes shape coordinates to assess patterns in 
conjunctival pathology. We used principal components 1 and 2 to collapse our 
multidimensional data into two dimensions explaining >60% of the variation in shape to 
visualize disease space. The picknplot() function in ‘geomorph,’ then allowed us to visualize 
the distortion of eye shapes along each axis with thin-plate spline deformation plots. Finally, 
plotting eyes with multiple specimens along these axes allowed us to evaluate disease 













Figure 4.2  Specimens aligned by Procrustes superimposition using package ‘geomorph’ in 
R. Large black circles define landmark means across all specimens, and small grey circles 
denote the landmark positions from individuals specimens. Links define the inner and outer 
eye rims. 
Technique 2: Community Analysis 
We derived paired data points comparing early versus late stage pathologies from 
experiments carried out in 2017 and 2018 using the same source population of house finches 
(Iowa) and strain of finch MG (‘VA1994’). All eyes used for the above shape analysis are 
also represented in this data set. At the time of severity scoring, a single observer (J. 
Adelman) evaluated eyes for the presence (1) or absence (0) of a community of pathological 
descriptors: blepharospasm, crusting, erythema, eversion, exudate, and swelling. To ensure 
that healthy eyes could be included in our subsequent community analyses, we added a 
‘health’ descriptor: eyes with no pathology received a 1 for this category, while eyes with 
one or more pathological descriptors present received a 0. Eyes that received the same 
severity score pre- and post-peak pathology were then included for community analysis, such 
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that a single bird may be represented multiple times across eyes and scores. When birds 
received the same eye score consecutively, we used the sample closest to peak pathology. We 
did have rare instances in which eyes scored the maximum eye score (3) over multiple days. 
To accommodate these samples, we used the first and last day an eye received this severity 
score. 
The following analyses are borrowed from community ecology, treating descriptors 
like species and eyes like unique sites that support different communities of pathological 
descriptors. We used the R package ‘vegan’ (Oksanen et al. 2019) to calculate Jaccard’s 
dissimilarity indices followed by multidimensional scaling based on principal coordinates 
analysis with package ‘geomorph’ to visualize community differences. We then used 
ANOVA to evaluate fixed effects of eye score, status, and their interaction on the distance 
matrix using a randomized residual permutation procedure (lm.rrpp). Lastly, we used 
package ‘indicspecies’ (De Caceres and Legendre, 2009) to carry out multi-level pattern 
analysis, which allowed us to identify indicator species (descriptors) predictive of status (pre- 
versus post-peak pathology). 
Population Comparison Study 
We also applied the techniques described above to a novel dataset to explore host-
pathogen evolution in multivariate trait space. Photographs, severity scores, and descriptors 
were collected on days 0, 3, 7, 14, 21, 28, and 34 for two populations of house finch 
experimentally-infected with two strains of Mycoplasma gallisepticum. Populations varied by 
length of pathogen establishment, with one originating from a region that has experienced 
seasonal epizootics in the wild for over twenty-five years (Virginia) and one originating from 
a region where the disease has never been reported and is presumed absent (Hawaii) 
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(Dhondt, Tessaglia and Slothower, 1998). We then experimentally-infected birds from each 
population with either the original isolate (VA1994) or a recently derived, virulent isolate 
(VA2013). 
 We used the methodologies described above to compare both eye shape and 
community composition across populations and pathogen isolates. For shape analysis, we 
limited specimens to left eyes to reduce non-independence. For community analysis, 
Jaccard’s distances were calculated using the presence or absence of descriptors by bird-day. 
We then ran ANOVAs on either the Procrustes shape coordinates or the distance matrix to 
evaluate the effects of strain, population, and their interaction using randomized residual 
permutation procedures. We also evaluated the level of dispersion, or average distance to the 
group centroid. Finally, we used multi-level pattern analysis to test for the differential 
expression of ‘indicator’ descriptors based on time since pathogen establishment. 
Results 
Paired Specimen Study 
Technique 1: Shape Analysis 
We digitized 90 paired images of 56 unique eyes from 47 birds to evaluate the effects 
of lesion severity and stage of infection on eye shape. This dataset included the full range of 
observer-assigned eye scores: 46 paired 0’s, 19 paired 0.5’s, 15 paired 1’s, 5 paired 1.5’s, 2 
paired 2’s, 1 pair of 2.5’s, and 2 paired 3’s. Despite small sample sizes at higher eye scores, 
we found clear trends in eye shape, described below. 
 We used principal components analysis to compress the Procrustes shape coordinates 
derived from landmarks into a single coordinate representing the centroid (mean) for each 
specimen. We then plotted these coordinates along principal components 1 and 2 (Figure 4.3) 
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such that the distribution of specimens represented occupied disease space. This plot further 
revealed that eyes return to the same relative location in disease space following the 
resolution of pathology (black squares, Figure 4.3). 
 
Figure 4.3  Principal components analysis on Procrustes shape coordinates colored by eye 
score. Thin-plate spline deformation plots provided to visualize disease space along PC axes. 
 To fully interpret the path through disease space, we introduced status to provide 
some measure of temporal resolution across specimens. Because birds reached different peak 
pathologies on different days, using status allowed us to bin specimens by score and stage of 
infection to calculate mean centroid locations for how birds move through disease space 
(Figure 4.4a). Again, the locations for scores >1.5 should be interpreted with caution due to 
small sample sizes. In general, however, infected eyes appeared to move clockwise through 
disease space (Figure 4.4a), returning to baseline in the same approximate location they 
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started. This pattern was consistent when we plotted individual trajectories for eyes with 
enough paired samples to fully capture the disease cycle (n = 6, Figure 4.4b).  
 
Figure 4.4  Trajectory of mean eye shape through disease space (a) as well as trajectories of 
individual eyes over the course of single infection cycles reflecting a range of severities (b). 
All trajectories follow a clockwise progression. 
We found significant fixed effects for eye score (0-3; F6,173 = 10.95, Z = 7.43, p < 
0.01), status (pre- or post-peak; F1,178 = 5.08, Z = 2.89, p < 0.01), and their interaction (F6,173 
= 2.64, Z = 3.45, p < 0.01) on eye shape. However, we should interpret the score x status 
interaction with caution as we had small sample sizes for eye scores >1.5. That being said, 
pairwise comparisons across all score and status combinations suggest that pre-peak 1.5’s 
have a unique shape signature, as they significantly diverge from pre- and post-peak 0’s, 
0.5’s, and 1’s (Z > 2.00, p < 0.04), as well as post-peak 1.5’s (Z = 5.52, p = 0.001). Just one 
other contrast was significant (pre-0 : pre-1; Z = 2.16, p = 0.02). 
Technique 2: Community Analysis 
The dataset used for this analysis included 114 paired samples of 66 unique eyes from 
36 birds. Of these, 46 pairs had observer-assigned eye scores of 0, 25 had scores of 0.5, 21 
had scores of 1, 12 had scores of 1.5, 4 had scores of 2, 2 had scores of 2.5, and 4 had scores 
of 3. 
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We extracted the ordinal scores for site (eye-day) from the distance matrix and 
plotted them along the principal coordinate axes to evaluate trends in community 
composition (Figure 4.5). Each circle represented a unique community of descriptors 
separated from other communities by its dissimilarity index, or extent of descriptor overlap. 
Circle size was scaled by abundance. Mean ordinal location shifted slightly down the PCoA2 
axis with lesion severity, quantified by observer-assigned eye score. Score (F6,221 = 63.10, Z 
=11.68, p < 0.01), status (F1,226 = 1.89, Z = 2.03, p = 0.03), and their interaction (F6,221 = 
1.77, Z = 3.22, p < 0.01) were significant sources of variation in the distance matrix of 
Jaccard’s dissimilarity indices.  
 
Figure 4.5  Principal coordinates ordination plots by eye score (ES, a-f) of Jaccard’s 
dissimilarity indices separating descriptor communities. Points are colored by stage of 
infection (pre- versus post-peak pathology) and scaled by abundance. 
 
67 
Multi-level pattern analysis identified exudate as a marginally significant indicator of 
eyes in pre-peak pathology (p = 0.08). Of eyes with pathological descriptors, exudate was 
present in 23.5% (16/68) of pre-peak eyes compared to 10.3% post-peak eyes (7/68). 
However, among eyes that scored a 1, 38.1% (8/21) showed exudate pre-peak compared to 
none post-peak. No other descriptors separated out by status. 
Population Comparison Study 
Technique 1: Shape Analysis 
We digitized 255 images of 41 unique birds, including 129 eye-days from Virginia-
origin birds (n = 69 for VA1994, n = 60 for VA2013) and 126 eye-days from Hawaii-origin 
birds (n = 69 for VA1994, n = 57 for VA2013). We separated out strain by population and 
plotted Procrustes shape coordinates along principal components 1 and 2 to compare 
occupied disease space (Figure 4.6). As reflected by the spread of coordinates, Hawaii-origin 
birds showed greater dispersion in eye shape across disease space than Virginia-origin birds 
(p < 0.01). 
 
Figure 4.6  Principal components analysis on Procrustes shape coordinates of birds 
challenged with VA1994 (a) or VA2013 (b), colored by population of origin. 
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We then compared individual trajectories through disease space by linking specimens 
from the same bird as it progressed through the disease cycle (Figure 4.7). Missing 
specimens appear as line breaks. Of note, because only left eyes were used for this analysis, 
birds appear to progress through disease space in a counter-clockwise direction, unlike the 
paired specimen analysis in which we reflected left eyes to superimpose onto rights. Overall, 
we found a significant fixed effect of population (F1,253 = 9.11, Z = 3.43, p < 0.01) but not 
strain (F1,253 = 1.88, Z = 1.25, p = 0.11) on eye shape. We repeated this analysis using a 
subset of specimens (n=41) for birds at maximum pathology, as determined by observer-
assigned eye scores, to correct for non-independence. Population remained a significant 
explanatory variable for eye shape (F1,39 = 3.01, Z = 1.54, p < 0.05). 
 
Figure 4.7  Trajectories of individual birds challenged with VA1994 (a) or VA2013 (b). Plots 





Technique 2: Community Analysis 
This dataset included 116 eye-days from Virginia-origin birds (n = 60 for VA1994, n 
= 56 for VA2013) and 126 eye-days from Hawaii-origin birds (n = 66 for VA1994, n = 60 
for VA2013). Of note, we excluded pre-infection data (day 0) as all birds started at health. 
We extracted the ordinal scores for site (bird-day) from the distance matrix and 
plotted them along the principal coordinate axes to evaluate trends in community 
composition (Figure 4.8). Population (F1,240 = 11.46, Z = 4.09, p < 0.01) and strain (F1,240 = 
13.26, Z = 4.16, p < 0.01) were significant sources of variation in the distance matrix of 
Jaccard’s dissimilarity indices. The interaction term was not significant and so it was 
removed from the linear model. Again, we repeated the analysis using a subset of specimens 
(n=41) for birds at maximum pathology to correct for non-independence. Though population 
remained a significant explanatory variable (F1,39 =66.34, Z = 5.76, p < 0.01), strain did not 
(F1,39 = 1.41, Z = 0.88, p = 0.21). We found unequal dispersion in the descriptor communities 
of Virginia and Hawaii birds (p < 0.01). Specifically, Virginia birds challenged with VA1994 
showed significantly smaller variance in location (narrower expression of pathological 
descriptors) than any other group (pairwise comparison: p < 0.01). 
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Figure 4.8  Principal coordinates ordination plots of Jaccard’s dissimilarity indices 
separating descriptor communities for birds challenged with VA1994 (a) or VA2013 (b). 
Points are colored by population of origin and scaled by abundance. Large circles to the left 
of plots reflect bird-days without pathology (health=1). 
We then evaluated for indicator pathologies by population broken out by strain. For 
VA1994, all pathological descriptors grouped with Hawaii (stat > 0.19, p < 0.03), and the 
health descriptor grouped with Virginia (stat = 0.30, p < 0.01). For VA2013, all pathological 
descriptors grouped with Hawaii, and all but eversion had significant associations (stat > 
0.19, p < 0.04; eversion: stat = 0.13, p = 0.17). The health descriptor continued to group with 
Virginia but was only marginally significant following challenge with the more virulent 
isolate (stat = 0.17, p = 0.09). Bird-days without pathology are represented by the larger 
circles centered over coordinates (-0.35, -0.01) in Figure 4.8. 
Discussion 
Lesion scores provide a convenient metric for monitoring the prevalence and spread 
of diseases that cause external pathology in free-ranging wildlife (Work and Balazs, 1999; 
Roberts, Nolan and Hill, 2001; Obendorf, 2005; Lachish, Jones and McCallum, 2007; 
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Reichard and Kunz, 2009; McCoy, Lind and Farrell, 2017). However, in the process of 
collapsing complex, multidimensional trait space into a discrete value, we may lose 
important contextual details like stage of infection or prognosis. Here, we introduce two 
novel techniques for capturing patterns in a multivariate response variable using one of the 
best characterized wildlife disease systems with external pathology, finch mycoplasmosis. 
Borrowing methods from geometric morphometrics and community ecology, we demonstrate 
how multivariate analyses can improve our understanding of pathology in this system, both 
in terms of single infections as well as within a co-evolutionary framework.  
 Based on shape analysis, we found that finch eyes occupy unique areas of 
multidimensional disease space depending on the severity and stage of infection. 
Specifically, we see that eyes with mild disease (e.g., 480.L, peak eye score = 1.5/3; Figure 
4.4b) track much closer to the origin than eyes with severe disease (e.g., 318.R, peak eye 
score = 3/3; Figure 4.4b). We also see that all eyes move through disease space in a 
clockwise progression. Given this consistency, it is plausible that we could stage infections 
using single snapshot evaluations of pathology in wild individuals. In particular, 
distinguishing between recently infected animals and those in recovery could improve our 
temporal resolution when tracking new disease introductions or seasonal epizootics (e.g., 
Pepin et al., 2017). 
Based on community analysis, we found that the composition of pathological 
descriptors changes with severity score. Specifically, as eyes increased in observer-assigned 
eye score, descriptor communities occupied different areas of multidimensional disease space 
defined by unique suites of pathological descriptors (Figure 4.5). We also saw less constraint 
over community composition for eye scores of 1, suggesting more inter-eye variability when 
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pathology is mild (Figure 4.5). In addition, we found that exudate was weakly predictive of 
eyes in early-stage disease, which like trajectory analysis, could improve the temporal 
resolution of disease investigations. In particular, this could lend itself to direct field 
applications, like deciding when to collect swabs for pathogen culture, as samples from 
recent infections tend to grow better in culture (Raka, 2012). Therefore, evaluating for the 
presence of exudate could make for an easy screening procedure of birds with mild 
pathology. 
In addition, we found marked population-level differences in eye shape and the 
expression of pathological descriptors according to pathogen strain and length of pathogen 
establishment. Hawaii birds experienced greater distortions of the eye rim, consistent with 
more severe conjunctival pathology, compared to Virginia birds, which converged on a 
narrow focus of multidimensional disease space (Figure 4.6). Yet, it was the Hawaii birds 
that occupied more constrained trait space by community analysis due to the expression of 
fuller and more consistent suites of pathological descriptors (Figure 4.8). By contrast, 
Virginia birds experienced more bird-days in health and only expressed a handful of 
descriptors predominated by swelling and exudate. These patterns intensified with the more 
virulent isolate, such that Virginia birds expressing more variable descriptor communities 
explored a greater extent of disease space than Hawaii birds (Figure 4.8b). 
 Given that all pathological descriptors grouped with Hawaii in our indicator 
analyses, we can infer that birds will express all pathologies when disease phenotype is not 
yet under selective pressure. In this way, Hawaii birds provide a baseline expression profile 
for how Virginia birds may have first responded to MG infection. However, after more than 
25 years of host-pathogen co-evolution, we see selection against pathology in Virginia birds. 
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That is certainly the most striking contrast across populations, regardless of strain. But, if we 
consider the association of descriptors within strain, we find a subtle nuance. Following 
challenge with VA2013, all pathological descriptors (p < 0.04) but eversion (p = 0.17) 
predict Hawaii as the population of origin, suggesting that Virginia birds express eversion 
differently from other descriptors. Because everting the conjunctiva increases the surface 
area available to shed pathogen without incurring an obvious fitness cost to the host (i.e. no 
loss of function), it follows that host-pathogen co-evolution would select for this pathology. 
In fact, it was a common wild-type pathology encountered in the field in Iowa, where MG 
has been circulating since 1996 (R. Ruden, personal observation; Dhondt et al. 1998). This is 
in contrast to pathologies like exudate, which may enhance shedding but also lead to 
sequelae like crusting, functional blindness, and reduced host survival, thus conferring 
limited selective advantage to the pathogen.  
Taken together, our results build upon recent efforts to infer stage of infection and/or 
predict disease outcomes based on multivariate data collected at discrete points. For example, 
Torres and colleagues (2016) found that mice infected with the malarial parasite Plasmodium 
chabaudi progressed through disease space in fairly predictable loops. Although their 
analyses reflected only two univariate metrics at once, the authors found that early infection 
performance could predict infection outcomes—when individuals entered ‘danger zones’ in 
disease space from which they would not recover. We saw just a hint of this in eyes 75.R and 
318.R that originated further to the right along PC1 and went on to experience worse 
pathology than their cohort (Figure 4.4b). Perhaps baseline eye shape explains some of the 
individual variation we see in disease progression, pre-disposing birds to certain types of 
conjunctival pathology. Similarly, several Hawaii birds spent weeks treading the same region 
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of disease space such that their disease loops remained open on day 34 (Figure 4.7). 
Evaluating such differences in multivariate disease trajectories may reveal similar “danger 
zones” to those seen in malarial infection, and from a clinical perspective, improve early 
prognostic indicators of individuals requiring therapeutic intervention. 
Overall, our results suggest that measuring external pathology with multivariate 
techniques captures information that is distinct from observer-assigned severity scores, which 
can improve our understanding of disease outcomes and host-pathogen interactions more 
broadly. Such methods could open up a new branch of inquiry in disease ecology and offer 
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CHAPTER 5.    GENERAL CONCLUSIONS 
Variable responses to pathogenic challenge produce different disease outcomes in 
animals. For instance, tolerant hosts experience lower fitness costs than intolerant hosts 
infected with the same quantity of pathogen. Phenotypically, tolerance manifests as milder 
clinical signs that bring individuals closer to pre-infection baselines of health. Thus, disease 
phenotypes like tolerance can have important ramifications on population-level disease 
dynamics, including infection intensity and spread. The over-arching aim of this dissertation 
was to characterize sources of variation in disease phenotype and evaluate their impacts on 
pathogen dissemination using finch mycoplasmosis, an ecologically-relevant disease system, 
as a model. 
The second chapter explored the physiologic underpinnings of disease tolerance as it 
related to the inflammatory pathway. By treating infected birds with chemotherapeutics, I 
was able to suppress the cyclo-oxygenase pathway that recruits the inflammatory mediators 
of immunopathology. In the first study, treated birds showed marked reductions in 
conjunctival pathology compared to control birds despite comparable bacterial burdens. In 
other words, treatment brought infected birds closer to baseline metrics of health. I was 
therefore able to induce a tolerant disease phenotype by dampening the pro-inflammatory 
response to infection mediated by the COX pathway, suggesting that disease phenotype is a 
plastic host trait regulated by inflammation. I followed up on these findings with a second 
study evaluating whether we could manipulate disease phenotype by suppressing 
inflammation during early infection. Restricting treatment to 3 or 7 days post-inoculation 
actually appeared to push birds toward an intolerant phenotype. But perhaps more intriguing 
was a pattern that crossed all treatment groups: birds that went on to develop severe 
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pathology consistently received higher eye scores than their cohort during the first week of 
infection. This suggests that host responses during early infection determine disease 
phenotype. So, isolating those responses will improve our understanding of the mechanistic 
drivers of disease tolerance in this system. 
The third chapter drew upon the natural variation in disease phenotypes to explore the 
influence of tolerance on host competence. Specifically, I simulated outbreaks in 12 house 
finch pairs and regressed metrics of tissue-specific and behavioral tolerance against time to 
transmission. As predicted, birds that developed milder pathology (higher tissue-specific 
tolerance) took longer to transmit pathogen, suggesting they were less competent hosts. In 
contrast, birds that expressed milder sickness behaviors (higher behavioral tolerance) 
transmitted pathogen more quickly, suggesting they were more competent. These findings 
are consistent with what others have observed in this system, particularly considering the 
critical role bird feeders play as sites for transmission. Moreover, tissue-specific tolerance 
was a significant predictor of time to transmission in the top five most supported models, 
suggesting that host pathology is a critical determinant of host competence. 
Because pathology enhances pathogen deposition at bird feeders, a natural 
progression of host competence studies beyond Chapter 3 would be to compare pathogen 
deposition across descriptive pathologies (e.g., blepharospasm, crusting, erythema, eversion, 
exudate, and swelling). The current paradigm of measuring pathology along a severity scale 
of 0-3 may miss more subtle effects of individual variation that further drive host 
competence. The studies in the first two chapters treat disease phenotype along a single axis, 
such that birds are either more or less tolerant. However, measuring pathology as a 
multidimensional response variable will permit us to consider a spectrum of disease 
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phenotypes, as well as their causes and consequences in this system. 
The fourth chapter accomplished just this task, using multivariate techniques to 
capture and then characterize variations in conjunctival pathology. A fundamental limitation 
of using severity scores is that birds rise and fall through the same values, offering no 
temporal resolution as to their location along individual disease trajectories. Yet, by pairing 
images according to severity score before and after peak pathology, I found that eyes 
occupied distinct and predictable regions of disease space as they advanced through the 
disease cycle. Thus, by leveraging the power of trajectory analysis, we may be able to stage 
individual infections using changes in eye shape to infer time since pathogen exposure. 
Moving forward, there are a range of applications for using shape analysis, and more 
specifically trajectory analysis, to evaluate disease phenotypes. Perhaps most intuitive given 
the studies presented in Chapter 1 would be using the area within the loop (Figure 4.4b) as a 
measure of range tolerance. Eyes that tracked closer to the origin had lower peak severity 
scores than those that tracked further out into disease space. Therefore, incorporating this 
suite of multivariate information into our tolerance estimates may provide a more holistic 
measure of disease severity. 
Evaluating communities of pathological descriptors hinted at profound differences in 
disease phenotype across birds from Virginia and Hawaii. Because Hawaii birds are naïve to 
finch mycoplasmosis, they tended to converge on the same focal area of disease space with 
communities that contained four or more descriptors representing the majority of eye days 
with pathology. By comparison, Virginia birds appeared unconstrained by a generalized 
inflammatory reaction, targeting instead specific pathologies, like eversion, that could 
increase host competence. Selection on lesion characteristics may be an under-explored area 
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of host-pathogen coevolution, affording a simple, testable hypothesis that could be addressed 
with the aforementioned study comparing pathogen deposition across pathologies. 
Overall, this dissertation shed light on the mechanistic and evolutionary drivers of 
host variation in disease phenotype. It then linked this variation to individual and population-
level disease outcomes, joining a burgeoning literature to emphasize the importance of host 
heterogeneity in shaping infectious disease dynamics. 
 
